Levofloxacin Renal Clearance
Yes, levofloxacin is primarily cleared by the kidney, with approximately 80% of the drug eliminated unchanged in the urine through glomerular filtration and tubular secretion 1.
Pharmacokinetic Evidence
The FDA drug label confirms that levofloxacin undergoes minimal metabolism in humans, with approximately 87% of an administered dose recovered as unchanged drug in urine within 48 hours 2. The renal clearance ranges from 96 to 142 mL/min, which exceeds the glomerular filtration rate, indicating that active tubular secretion contributes to renal elimination in addition to glomerular filtration 2.
Renal clearance in excess of the glomerular filtration rate confirms that tubular secretion is an important mechanism of levofloxacin elimination. This is further supported by the observation that concomitant administration of probenecid (which blocks tubular secretion) results in approximately 35% reduction in levofloxacin renal clearance 2.
Clinical Implications for Renal Dysfunction
Because of predominant renal clearance, dosage adjustment is mandatory when creatinine clearance falls below 50 mL/minute 1. Multiple guidelines consistently recommend:
- For creatinine clearance <30 mL/min or hemodialysis patients: 750-1,000 mg three times weekly (not daily) 3, 4, 3
- For creatinine clearance 20-49 mL/min: 500 mg loading dose, then 250 mg every 24 hours 5
- For creatinine clearance 10-19 mL/min: 500 mg loading dose, then 250 mg every 48 hours 5
The plasma elimination half-life is substantially prolonged in renal insufficiency, increasing the risk of drug accumulation and toxicity if doses are not adjusted 2.
Hemodialysis Considerations
Levofloxacin is NOT effectively removed by hemodialysis, so supplemental doses after dialysis are not necessary 1. This contrasts with some other renally cleared antibiotics. The drug should be administered after hemodialysis sessions to facilitate directly observed therapy and avoid any potential premature clearance 3, 4, 3.
Contrast with Hepatic Clearance
Unlike many other fluoroquinolones (such as moxifloxacin), levofloxacin does not undergo significant hepatic metabolism 3, 6. Drug levels are not affected by hepatic disease, and no dose adjustment is needed for liver dysfunction 1. This makes levofloxacin distinct from moxifloxacin, which undergoes greater hepatic metabolism and has less renal clearance 3, 6.
Key Clinical Pitfalls
- Do not use standard doses in patients with creatinine clearance <50 mL/min - this will lead to drug accumulation and increased toxicity risk
- Measure creatinine clearance, not just serum creatinine - elderly patients may have normal serum creatinine despite significantly reduced renal function due to decreased muscle mass 2
- Consider therapeutic drug monitoring in ESRD patients to ensure adequate exposure without excessive accumulation 3, 4, 3
- Remember that elderly patients (≥65 years) are at higher risk for severe adverse events including tendon rupture and hepatotoxicity, particularly when renal function is impaired 2